Clinical Trial Update: 3-5 FrAction Stereotactic Body Radiation Therapy for Palliation of Head and Neck Squamous Cell Carcinoma: the FAST Phase II Randomized Trial [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov listing describes a Phase II randomized trial (FAST) evaluating 3-5 Fraction Stereotactic Body Radiation Therapy for palliation in head …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING